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-alkylguanine-DNA-alkyltransferase (AGT) has been implicated in reducing 
the therapeutic efficacy of alkylating agents that cause mutations and apoptosis.
 
Certain 
chemotherapeutic treatments involve the use of alkylating agents; bis-
chloroethylnitrosourea (BCNU) is an example of an agent that has been investigated 
which has been shown to introduce DNA interstrand crosslinks (ICL). AGT directly 
repairs O
6
-alkylated guanines by flipping the damaged base into the active site and 
irreversibly transferring the alkyl group to an active site cysteine.  Previous studies 





-2’-deoxyguanosine (O6-dG-heptylene-O6-dG) ICL in a 5’-GNC-3’ motif 
mimicking a hepsulfam lesion. It is not yet understood, however, how the enzyme could 
access the bulky ICL lesion.  





ICL lesion in a 5’-GNC-3’ motif (where N is any base) and a fluorescent base 
incorporated at various positions to observe the extent to which DNA is denatured upon 
AGT binding. 6-Methyl-3-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d] pyrimidin-2-one 
(pyrrolo-dC), is a base analog that fluoresces when not base-paired and exhibits little 
effect on DNA stability, structure and AGT repair. All DNA substrates were synthesized 
and AGT homologs purified and characterized using various biophysical techniques 
including CD, UV spectroscopy, gel electrophoresis and MS-Q-TOF. Radioactivity 
binding and repair assays were used to characterize ICL-AGT association. The DNA 
substrates exhibited B-form structure regardless of pyrrolo-dC or ICL incorporation. 
Furthermore, C145S and R128A variants of AGT and wild type Ada-C (from E. coli) 
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display no repair of the ICL DNA. The arginine ―finger‖ (R128) appears to play an 
essential role in repair but not in damage detection. Incorporation of pyrrolo-dC did not 
specifically demonstrate the extent of DNA denaturation due to the observation of 
increased fluorescence when positioned near the end of the DNA double helix relative to 
when placed in the center of the duplex. Fluorescence studies provide a base with which 
to develop new AGT variants with more complex ICL DNA substrates to study their 
interaction and possibly provide a new method for determining binding dissociation 
constants without hazardous radioactive material. Better understanding of the interaction 
of AGT and its homologs with ICL DNA provides greater knowledge about AGT 
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DTT: Dithiothreitol 
dsDNA: Double stranded deoxyribonucleic acid 
EDTA: Ethylenediamine tetraacetate 
eq.: equivalence 
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Chapter 1: Introduction 
1.1 General background 
Organisms are constantly under threat of damaging events that undermine their 
ability to function, one of the major targets being deoxyribonucleic acid (DNA). Genomic 
DNA contains all the genetic material required for cell development and is the template 
for transcription of mRNA, which is required for the synthesis of various proteins that 
perform essential biological functions. DNA is vulnerable to a variety of damaging 
events: UV radiation, chemicals and various endogenous and exogenous species
1, 2
. Since 
Muller’s discovery of the mutagenic effects of X-rays in 1927 and subsequent interest in 
the effects of mutagenic chemicals, it was not until the 1940s that repair mechanisms 
were beginning to be understood
3
. Ever since, researchers have been interested in the 
study of the effects of damaging events on cell survival and their ability to reverse it. This 
has led to the discovery and in-depth study of repair systems over the last 70 years
4, 5
.  
In order to maintain cell integrity, various DNA repair pathways exist. These 
involve proteins whose specific function is to repair DNA acting on damaged or modified 
bases; one such class of proteins is the alkyltransferases, such as O
6
-alkylguanine-DNA-
alkyltransferase (AGT). AGT repairs the alkylated O
6
 position of guanine reversing the 
effects of certain alkylating agents, reducing the incidence of mutation and apoptosis
6-55
.  
 Greater knowledge of cellular repair machinery allows for increased 
comprehension of how the cell functions and improves our abilities to stave off and 
combat cancers and diseases. More specifically, a better understanding of the interaction 
of AGT and its homologs with various forms of alkylated DNA will provide greater 
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knowledge about AGT function, an enzyme that plays a role in both restoring genomic 
integrity and therapeutic resistance.  
1.2 DNA and DNA damaging events 
Although considered more chemically stable than proteins and RNA, DNA is 
subject to spontaneous depurination and chemical alteration by oxidative species, UV 
radiation and alkylating agents
1, 2
. These DNA damaging events may cause double strand 
DNA breaks, depurination, oxidized bases (eg: 8-oxo-2’-deoxyguanosine), thymine-
thymine cyclobutane pyrimidine photodimers, alkylated bases (eg: O
6
-methyl-
deoxyguanosine) and interstrand crosslinks to name a few
1, 2, 11, 56, 57
. Due to the range of 
damage that can be caused, researchers have realized the potential of employing synthetic 
alkylating agents as a treatment to induce cell death of fast-replicating cancer cells.  
1.2.1 Alkylating agents 
Alkylating agents are chemically electrophilic and target the nucleophilic sites of 
DNA. DNA has multiple nucleophilic sites but not all sites are equally susceptible to 
alkylation (see Table 1). Using mono-functional alkylating chemicals, methyl 
methanesulphonate (MMS) and N-methyl-N-nitrosourea (MNU), researchers were able 
to observe the sites of DNA that are most prone to alkylation. They observed that the 
most nucleophilic sites appear to be N3 of adenine, O
6
 and N7 of guanine and the non-
bridging oxygen atoms of the phosphodiester group. Mono-functional alkylating agents 
can only affect one nucleophilic site, whereas a bi-functional agent can affect two sites 
and may form crosslinks, such as an N7-heptylene-dG-N7-heptylene-dG interstrand 
linkage of hepsulfam. 
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Site of methylation MMS + dsDNA MMU + dsDNA 
Adenine 
N1- 3.8 1.3 
N3- 10.4 9 
N7- 1.8 1.7 
Guanine 
N3- 0.6 0.8 
O
6
- 0.3 6.3 




- ND 0.11 
N3- ND 0.3 
O
4




- — 0.1 
N3- <1 0.6 
Phosphodiester backbone 0.8 17 
Table 1 Methylation patterns of double stranded nucleic acids upon reaction with MMS 
and MNU. Adapted from Drabløs F et al 2004
11
. The values herein are expressed as a 
percent of the total observed methylation. ND means not determined. 
There exist both endogenous and exogenous alkylating species, some naturally 
occurring while some are synthesized as a therapeutic agent. A well characterized 
endogenous species, S-adenosylmethionine, has been implicated in minor non-enzymatic 
methylation of DNA. Predominant sites of methylation are at the sites N7 of guanine and 
N3 of adenine
11, 58
. In addition, it has been observed that starving E. coli cells, deficient 
of alkyltransferase genes, were more predisposed to spontaneous mutations (G:C to A:T 




-methyl-dG damage can 
induce altered amino acid sequences upon transcription leading to mutant proteins that 
may be rendered non-functional or over-active, which could lead to apoptosis and 
cancer
70
. Furthermore, studies showed that addition of sodium nitrite enabled the 
nitrosation of various chemical species (eg: amides), by bacterial enzymes only, 
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 There are naturally occurring exogenous alkylating agents such as halocarbons
11
 
and by-products of combustion of plant materials, such as acrolein and crotonaldehyde
56
. 
Various synthetic agents are employed or have been studied as a therapeutic treatment for 
cancers. The first generation of therapeutic alkylating agents were mono-functional, 
adding a methyl group or larger alkyl groups to nucleic acids such as methyl 
methanesulphonate (MMS), N-methyl-N-nitrosourea (MNU) and temozolomide. 
Realising the potential of creating interstrand crosslinks and intrastrand crosslinks, bi-
functional alkylating agents such as bis-chloroethylnitrosourea (BCNU), busulfan and 
hepsulfam were developed (see Figure 1 for all chemical structures). ICLs are highly 
potent as they covalently link each DNA strand, blocking replication and transcription, 
possibly leading to apoptosis
60
. Although not specifically an alkylating agent, Cisplatin 
(cis-diamminedichloroplatinum (II)), a platinum-based chemotherapeutic treatment, 
predominantly forms intrastrand crosslinks that distort the DNA double helix, inhibiting 












































N-methyl-N-nitrosourea (MNU)methyl methanesulphonate (MMS) Temozolomide
bis-chloroethylnitrosourea (BCNU) Busulfan Hepsulfam
Figure 1 Chemical structures of various alkylating agents. Mono-functional alkylating 
agents (top) and bi-functional alkylating agents (bottom) are shown.  
 5 | P a g e  
 
 Despite the high potency of alkylating agents their mutagenic and cytotoxicity 
effects are significantly decreased in in vivo studies. The cell has a variety of defense 
repair mechanisms that reduce the therapeutic efficiency of alkylating agents. As such, 
researchers have synthesized a variety of modified DNA containing alkylated bases or 




1.3 Cellular DNA repair systems 
The cell has developed various DNA repair pathways to maintain integrity and to 
reverse mutagenesis. Some of the major pathways include: direct repair (DR), base 
excision repair (BER), mismatch repair (MMR), nucleotide excision repair (NER) and 
homologous recombination (HR). All of these pathways require complexes of protein, 
except direct repair, and a complicated signalling system. Interestingly, cells have 
evolved in such a manner that there is an overlap of repair systems for a given mutagenic 
DNA damage (see Figure 2). For instance, alkylated guanine can be repaired by certain 
direct repair proteins, NER and BER
2, 11, 34, 41, 60, 70
.  
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Figure 2 General scheme of DNA damaging events with corresponding damage and 
cellular repair pathway (modified from Blanpain C et al 2011)
70
. 
1.3.1 Direct Repair 
 Direct repair is one of the simplest repair pathways, often requiring only one 
protein. DR involves stoichiometric reversal of damage without significant disruption of 
the DNA double helix in a one-step mechanism such as alkyltransferases and photolyase. 
This system enables for fast and simple repair without the recruitment of large 
complexes. 
 When DNA is exposed to UV light, thymine-thymine cyclobutane pyrimidine 
photodimers and pyrimidine-pyrimidone (6-4) photoproduct (Pyr [6-4] Pyr) can form, 
which are mutagenic and cytotoxic. In order to reverse this damage, some organisms use 
photolyase. Over 50 homologs have been sequenced, showing sequence identities from 
17-70%. Photolyases are monomeric and require two cofactors, a photocatalyst and a 
photoantenna; FAD and methenyltetrahydrofolate (MTHF) or 8-hydroxy-7,8-didemethyl-
5-deazariboflavin (8-HDF) respectively. The FAD cofactor is required for interacting and 
Double strand breaks 






DNA repair  
Ionizing radiation 
X-rays 
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breaking the cyclobutane ring. The photoantenna absorbs light energy to transfer to the 
FAD cofactor. E. coli photolyase has been crystallized and characterized, yet there does 
not appear to be a human homolog. Human cells must use the more complex repair 
pathway NER to remove photodimer damage
57
. 
 Another major direct repair class of proteins are the alkyltransferases. There are 
two main types that will be discussed: O
6
-alkylguanine-DNA-alkyltransferase (AGT) and 
AlkB proteins. AGT will be discussed in further detail in the following section. AlkB was 
first discovered in 1983, when mutation of its gene resulted in an increase in 
mutagenesis
34
. However, it was only in 2002 that AlkB’s mechanism of action was 
discovered as the removal of alkyl damage through oxidation. More specifically, AlkB 
utilizes an iron (II), α-ketoglutarate and oxygen complex to catalyze the repair of N1-
methyl-adenine and N3-methyl-cytosine. This complex enables AlkB to form a 
hydroxylated methyl group intermediate that degrades to formaldehyde and an 
unmodified base (see Figure 3). Although AlkB repair results in an unmodified base 
similar to that of AGT, the mechanism of action is completely dissimilar
34
. 
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1.4 AGT background 
The first alkyltransferase protein discovered was the inducible E. coli Ada 
protein. It was determined that it could be induced in the presence of mutagenic agents
34
. 
Ada is composed of two distinct regions, the N- and C-terminal domains. The N-terminal 
was shown to repair alkylated phophodiester backbone, while the C-terminal reversed 
alkyl damage at the O
6
 position of guanine
19, 39, 49
. The C-terminal domain was isolated 
and purified (as Ada-C), its repair substrates and mechanism elucidated and crystallized
19, 
35, 45, 50
. Ada-C is a monomeric suicidal protein that irreversibly and stoichiometrically 
(1:1) transfers the alkyl damage to a cysteine in the active site. Although initial reports 
suggested that the protein had to make a significant conformational change in order to 
repair the modified DNA, it was later determined that the DNA double helix substrate 
was distorted upon Ada-C binding
50
. Ada-C appeared to be specific to methyl groups at 
the O
6
 position of guanine, with repair of O
6
-ethyl-dG being 1000 times less efficient and 
almost negligible repair of larger substrates or substituents at the O
4




In addition to Ada-C, a constitutively expressed E. coli homolog Ogt was 
discovered. Ogt has never been crystallized due to poor yields of purification; however, 










. In addition, studies showed Ogt’s ability to repair larger 
groups such as a heptyl group with a either a terminal hydroxyl or a 2’-deoxyguanosine 
(repaired to a lesser extent)
42
.  
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It was later discovered that humans possessed a protein homologous to both Ogt 
and Ada-C, namely O
6
-alkylguanine-DNA-alkyltransferase (AGT). The AGT human 
protein is a 22kDa protein found in many organisms with the exception of plants
39
. AGT 
is of interest as it has been implicated in reducing the therapeutic efficacy of alkylating 
agents that cause mutations and apoptosis.  
1.4.1 AGT structure 
The human protein is characterized by two domains; the N- and C-terminal. The 
C-terminal contains a conserved -Proline-Cysteine-Histidine-Arginine- (-PCHR-) active 
site, an arginine ―finger‖ (Arg128, see Figure 4), and a helix-turn-helix DNA binding 
motif. The N-terminal contains a zinc binding site. According to crystal structures of 
AGT with modified DNA (see Figures 5 and 6) the Arg128 residue is required to aid in 
flipping out the modified base into the active site and potentially stabilizing the double 
helix. The residue Tyr 114 also appears to assist in rotation of the alkylated base by 




Figure 4 Sequence alignment of AGTs from various organisms with the active site and 
the arginine ―finger‖ highlighted in yellow. 
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Furthermore, AGT binds DNA in the minor groove, where most DNA binding 
proteins bind the major groove. The binding of zinc appears to favour protein stability 
and increase its rate of repair
8, 9, 14
. It is also believed that with increasing stability of the 
protein, specifically the N-terminal, that a hydrophobic patch is formed which may play a 
role in protein-protein interactions
13
. Although the precise function of the zinc-binding 
site in the N-terminal of AGT is not understood, a study showed that the C-terminal could 
repair alkylation damage, but could do so more efficiently in the presence of its N-
terminal
14
. In other homologs the N-terminal demonstrates endonuclease V activity (in 
Ferroplasma acidarmanus) or can act as a signalling molecule (in E. coli Ada protein)
27, 
34
. There also exists a Caenorhabditis elegans homolog, cAGT-2, that lacks the 




Figure 5 Crystal structure (IT39) of AGT. The helix-turn-helix motif (light blue), active 
site (red), zinc binding site (orange) and the arginine finger (purple) are highlighted
8
. 
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1.4.2 AGT and mono-adducts 
Mono-adducts of guanine, such as O
6
-methyl-dG, can be repaired 
stoichiometrically and irreversibly by AGT. By means of an arginine ―finger‖ the 
damaged base is flipped into the active site where the alkyl group is irreversibly 
transferred to a highly reactive cysteine residue (Cys145 in human AGT, see Figure 6 
and 7)
20
. The Cys145 is an active nucleophilic species due to its placement within a 
glutamate-histidine-water-cysteine hydrogen bond network.  
 
Figure 6 An enlarged image, using pymol, of the IT39 AGT crystal structure, where 
AGT was co-crystallized with a modified base. Red denotes the active site cysteine 145 




The crystal structure clearly illustrates AGT’s mechanism of repair by flipping 
out the alkylated base with no major distortion or melting of the DNA double helix. In 
addition, it appears that the arginine ―finger‖ plays an essential role in damage reversal, 
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as was also verified by in vitro repair studies. Interestingly, AGT can repair an O
6
-alkyl-
guanine in dsDNA regardless of the base directly opposite the alkylated guanine adduct
43, 
47
.  In addition, AGT has demonstrated a lack of sequence dependence of the flanking 
residues when repairing alkylated guanine and reverses damage in a cooperative manner
3
.  
Studies have shown that once alkylated, AGT becomes ubiquitinated and 
consequently degraded, in addition to becoming more sensitive to protease digestion in 
vitro
25, 44, 54
. Furthermore, a novel function of AGT as a signalling molecule was 
discovered, where it acted as a negative regulator of estrogen-receptor mediated 
transcription
73
. Although not considered inducible as in the case of the Ada protein, 
studies showed that partial hepatectomy and an increase in glucocorticoids results in 




Figure 7 AGT repair mechanism of O
6
-methyl-dG (modified from Daniels DS 2004)
 9
. 
AGT, unlike its E. coli counterparts, is able to repair a wide variety of alkyl 
damage both at the O
6
-atom of guanine (see Figure 7) and the O
4
-atom of thymine, but to 
a lesser extent. AGT can repair substrates as small as methyl groups to much larger 
benzyl groups and even ICLs (see Figure 8). The human homolog is able to 
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Figure 8 Simplified AGT reaction and examples of repairable substrates
39
. 
 Due to AGT’s ability to repair a wide variety of alkyl damage, it became apparent 
that inhibition of this protein could play a therapeutic role in cancer treatment
16, 17
. AGT’s 
role in reducing therapeutic effectiveness of various alkylating agents was supported with 
in vivo assays
7, 10, 46
. As a result of AGT’s importance several detection assays have been 
developed, from real-time fluorescence assays, to restriction endonuclease inhibition and 
magnetic bead separation and action as a labelling molecule for small molecules
23, 53, 80
. 
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One of the major questions though, was how does AGT detect damage to repair it? In 
addition, was there a molecule that could be used to inhibit AGT to reduce its 
effectiveness? 
1.4.3 Damage detection 
A long standing question has been: How does AGT detect modified bases? 
Initial hypotheses believed that AGT actively flipped out each base as a means to detect 
repair (see Figure 9A), yet without the requirement of a cofactor or an energetic 
molecule (ATP) this seemed unlikely. Another hypothesis believes that AGT transiently 
detects extrahelical lesions (see Figure 9C) or is able to detect DNA intrahelical lesions 
based on DNA instability or distortion (see Figure 9B).  
 
Figure 9 Illustration of the various hypotheses of DNA damage detection by AGT
12
. 
Duguid et al approached the problem with a chemical crosslinking experiment 
using a modified base that was linked to a disulphide bond. On repairing the modified 
base, AGT would be chemically linked to the DNA strand (see Figure 10)
12
. Using a 
disulphide linking approach, they determined that AGT must sense modified bases by 
either detecting adducts that are hidden intrahelically or capturing transient extrahelical 
lesions, but not by actively searching for damaged bases. Conversely, the E. coli homolog 
Ada-C was only able to capture transient extrahelical lesions
12
.  
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Hu et al, using a computational approach, showed that AGT is able to scan DNA 





times faster into the active site than dG, and that AGT could move along the DNA 
strands 10
3
 times slower than O
6
-methyl-dG flipping, suggesting that AGT is able to scan 
the DNA and flip predominantly only O
6
-methyl-dG into the active site, whereas dG 





















Figure 10 Illustration of a modified cytosine to form a disulfide linkage between AGT 
and DNA (modified from Duguid et al 2003)
12
.  
Computational and experimental data have yet to fully agree on AGT’s ability to 
detect and scan for alkylated bases. Much work is still required before the exact 
mechanism of damage detection is elucidated. 
1.4.4 AGT and interstrand crosslinked DNA 
Certain chemotherapeutic treatments involve the use of alkylating agents that 
introduce DNA interstrand crosslinks (ICL); hepsulfam is an example. Although mono-
adduct repair has been researched in-depth, it is still unclear how AGT can access bulky 





-heptylene-dG lesion directly opposed and in a 5’-GNC-3’ motif (N is any base), and 
hypothesized that two AGT molecules are required (see Figure 11)
33
. MS studies 
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FP: Final Product 
MP: Median 
Product 
demonstrated that the 5’-GNC-3’ motif was the most favourable sequence motif for 
alkylation crosslink formation upon hepsulfam treatment
68
. 
Figure 11 Proposed repair scheme of ICL in a 5’-GNC-3’motif by AGT33. 
A model of repair has suggested that the DNA duplex is denatured and the 
repaired strand released, while the alkyl adduct and attached DNA remain covalently 
bound to AGT
15
. The model illustrates a completely denatured DNA double helix, where 
this varies drastically from mono-adduct repair. Development of binding assays to 
determine AGT’s mode of binding and repairing of ICLs is required to confirm the model 
and improve our understanding. 
1.4.5 AGT inhibitors 
AGT’s ability to diminish the therapeutic efficiency of various alkylating agents 
has inspired the development of inhibitors. Initial work began in 1990 when O
6
-benzyl-
guanine was used to deplete cellular AGT as a means to verify its function as a protectant 
against mutagenesis and alkylating agents
10
. Since that time, new inhibitors that mimic 
substrates have been developed (see Figure 12)
39
.  
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Figure 12 Inhibitors of AGT
39
.  
Inhibition of AGT is often monitored using mass spectrometry (MS) techniques 
or gels. Thus far, one of the major problems with inhibitor drug development has been 
poor solubility. Further development of AGT inhibition is still required before a 
treatment regimen can be commercialized. 
1.5 Fluorescent base analog to detect DNA denaturation 
There are several well-known fluorescent base analogs from 2-amino purine to 
6-methyl-3-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d] pyrimidin-2-one (pyrrolo-dC). We 
will be focusing our discussion on the development of pyrrolo-dC and its properties. In 
the 1980’s the first pyrrolo derivative was discovered, but it was not until 2004 that the 
pyrrolo-dC analog was developed and begun to be incorporated in DNA to study its 
properties (see Figure 13)
84
.  





























Figure 13 Representation of base pairing between guanine and cytosine (top) and 
guanine and pyrrolo-dC structure (bottom).  
Pyrrolo-dC is commercially available and characteristically stable under DNA 
solid-phase synthesis, with little apparent effect on DNA structure and stability
55, 74, 83, 86
. 
Pyrrolo-dC’s ability to maintain DNA structure and stability may be due in large part to 
its ability to base pair with guanine in much the same way as cytosine. In addition, 
pyrrolo-dC appears to discriminate well between the various bases, where it associates 
best with guanine, which is useful in DNA repair and base mismatch detection
76, 77, 82, 85
. 
An important property is that pyrrolo-dC fluoresces when not base paired, while it is 
quenched when base paired, more precisely in B-form DNA. Based on computational 
results, it is postulated that the observed quenching of pyrrolo-dC fluorescence is not 
mainly because it is base paired but due to the pi-pi stacking within B-form DNA
75, 83
. 
One study demonstrated that the position of pyrrolo-dC within a DNA double helix will 
have a differing fluorescence profile, where the position near the middle will show lower 
overall fluorescence emission as compared to a position near the end
76
. Pyrrolo-dC has 
been used for various assays, from being used in repair assays of AGT with benzylated or 
methylated guanine residues to a probe for the detection of silver ions
55, 81
. This 
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fluorescent base analog may allow for the ability to monitor DNA melting due to protein 
(AGT) binding. 
1.6 Research Objective 
Although the ability of AGT to repair an ICL has been investigated, the 
influence of AGT binding and effect on the structure of the ICL DNA duplex to access 
the damage is unknown. Therefore, to better understand the effect of AGT binding, a 
base that fluoresces when not base-paired (pyrrolo-dC), will be incorporated into 
oligonucleotides at various positions relative to the lesion, to observe whether DNA 
melting is occurring and the distance from the site of the lesion. The lesion will be an O
6
-
2’-deoxyguanosine-heptylene-O6-2’-deoxyguanosine (O6-dG-heptylene-O6-dG) ICL in a 
5’-GNC-3’ motif. This ICL DNA mimics the lesion formed by hepsulfam (a heptylene 
linkage between two guanines) and the sequences of the oligonucleotide substrates are 
shown in Figure 14. 
In order to achieve our goal, we will synthesize the ICL DNA and its controls, 
purify them to high purity and biophysically characterize the DNA. In addition, proteins 
(AGT wild type, C145S variant, R128A variant and Ada-C) will be expressed and fully 
characterized to ensure purity and proper folding. The C145S variant is inactive and will 
be used for binding assays while R128A variant has the arginine ―finger‖ replaced with 
an alanine in order to understand its role in ICL DNA repair and binding. Once complete, 
we can then begin to study their association using radioactivity repair and binding 
studies. Those proteins not able to repair and that bind strongly to the DNA substrates 
will then be selected for fluorescence binding assays. The fluorescence binding assays 
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will be monitoring the increase in fluorescence as emitted by pyrrolo-dC, and will give an 











-dG (top right) and N7-dG-heptylene-N7-dG 
(top left) linkages, and the oligonucleotide sequence (bottom) to be used with the ICL 
represented by the line between two guanines and the locations of pyrrolo-dC.  
Greater understanding of AGT’s association with ICL DNA as compared to 
unmodified DNA may shed some light in AGT’s ability to access these bulky ICL 
lesions. This will allow for the development of new ICL forming drugs that are resistant 
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1.7 Summary 
 DNA plays an essential role in cell survival and is protected by several repair 
pathways against both endogenous and exogenous DNA damaging events. Alkylating 
agents have been exploited for their mutagenic and cytotoxic effects by using them as 
chemotherapeutic agents. Even though alkylation damage can potentially be very potent 
and lethal, repair pathways have been shown to reduce the damaging effect and increase 
cell survival rates. One important repair pathway explored is direct repair, the simplest of 
all repair systems. Alkyltransferases, specifically AGT, have shown their ability to reduce 
the efficiency of various alkylating agents. AGT stoichiometrically and irreversibly repair 
O
6
-alkyl-dG in an efficient manner, after which it is ubiquitinated and degraded. In 
addition, AGT has shown to accommodate a wide variety of substrates including ICLs.  
As a consequence AGT inhibitors have been developed in the interest of improving 
therapeutic regimens. 
 Of interest is AGT’s ability to repair ICLs, as it is still unknown how this occurs. 
A fluorescence based binding assay will be explored in the hope of gaining a greater 
understanding as to how AGT associates with ICL and the extent to which DNA is 
distorted upon binding. Greater understanding of ICL-AGT association may allow for the 
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Chapter 2: Materials and methods 
2.1 Materials 
All biochemical reagents were purchased from Bioshop Canada Inc (Burlington, 
ON). Ni-NTA Superflow Resin was purchased from Qiagen (Mississauga, ON).  
Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets were obtained from 
Roche (Laval, QC). Nanosep 3K Omega and Sep-Pak
®
 C-18 cartridges were obtained 
from Pall Corporation (Ann Arbor, Michigan) and Waters (Wexford, Ireland), 
respectively. Unstained Protein Molecular Weight Marker was purchased from Fermentas 
Life Sciences (Burlington, ON).  
2.2 Site-directed mutagenesis 
 The AGT wild type plasmid was previously prepared by Francis McManus (Ph.D. 
candidate). The AGT gene was inserted into a pQE30 vector, IPTG inducible and AMP 
resistant, between EcoRI and KpnI cleavage sites. In addition, all primers (sequences 
shown in Table 2) were designed based upon the modification of a single residue, and 
were purchased from BioCorp (Montreal, Quebec). Phusion DNA polymerase and DpnI 
were obtained from Fermentas Life Sciences. 
The R128 residue of AGT wild type was replaced with an alanine (see Table 2 
for primer sequences) using the QuikChange® site-directed mutagenesis kit from 
Stratagene (Agilent, Mississauga, Ontario). As per the Stratagene recommendation, the 
reaction mixture (50 μL) contained 1 μL (5-10ng) of pQE30-AGTwt template, 2 μL 
dNTPs, 10 μL of 5X HF buffer, 0.5 μL of Phusion DNA polymerase and 1μL (10 pmol) 
of both forward and reverse primers. The mixture was then placed in a GeneAmp PCR 
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System9700 for 2-2.5 hours under the following temperature cycling conditions: 98°C, 2 
minutes; followed by 18 cycles of 98°C, 1 minute; 65°C, 1 minute; 72°C, 4 minutes; 
ending with  72°C for 10 minutes and cooling to 4°C. PCR sample was subsequently 
digested with 1 μL DpnI at 37°C for 2-2.5 hours. DpnI digests methylated DNA, resulting 
in digestion of the template DNA with only the PCR products remaining that may then be 
used to transform bacteria. 





CCC AAA GCC GCG CGA GCA GTG GGA GGA GG PKAARAVGG 
hAGT 
R128A 








CCC AAA GCC GCG GCA GCA GTG GGA GGA GG 
Table 2 Summary of modifications made (underlined), based on amino acid sequence 
(N- to C- terminal) and oligonucleotide sequence (5' to 3'), and the primers- using E. coli 
codons for optimum expression- employed for site-directed mutagenesis.  
2.3 Cell transformation 
 The DpnI digests of PCR based site-directed mutagenesis, 2 μL, is incubated with 
50 μL of competent XL-10 gold E. coli cells on ice for 2-5 minutes. The sample is 
subsequently heat shocked at 42°C for 40 seconds and cooled on ice for 2 minutes. The 
entire content were plated on LB agar/AMP plates and incubated at 37°C overnight.  
2.4 Extraction of plasmid DNA  
 Colonies formed from the bacterial transformation were selected and used to 
inoculate 10 mL 2XYT (16 g tryptone, 10 g yeast extract and 5 g NaCl in 1 L of water) 
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and 10 μL AMP (0.1 g/mL) shaking at 225rpm overnight at 37°C. Plasmid DNA was 
extracted via a GeneJET™ Plasmid Miniprep Kit (Fermentas Life Sciences) stored in 
distilled water at -20°C as per the manufacturer’s instructions. The plasmid DNA was 
quantified using UV spectroscopy at 260 nm with the assumption that double stranded 
DNA has an extinction coefficient of 50 ng μL-1 cm-1. Pure plasmid DNA was then sent 
for sequencing (Genome Quebec) and to be used to transform bacteria to express protein.  
2.5 Glycerol stock preparation 
 Colonies from transformed XL-10 Gold E. coli cells were used to inoculate 2XYT 
solution containing AMP (0.1 g/mL) that was incubated overnight at 37°C shaking at 225 
rpm. A 700 μL aliquot of E. coli cells and 300 μL of a 50% glycerol solution were then 
mixed and subsequently stored at -80°C. 
2.6 Protein purification 
Glycerol stocks of AGT wild type and variant were prepared by Francis 
McManus (Ph.D. candidate). Overnight cultures were grown in 10 mL of 2XYT and 10 
µL of AMP (0.1 g/mL) in a 50 mL falcon tube at 37
o
C in a shaker at 225 rpm. These 
were then used to inoculate 1 L of 2XYT and 0.1 g AMP at 37
o
C for 2.5 hours. When the 
culture reached an absorbance reading between 0.4-0.6 at 600nm, protein expression was 
induced by adding 4 mM IPTG and the culture was allowed to grow for another 4 hours. 
Cells were then centrifuged at 8500g using a Beckman J2-HS centrifuge for 20 minutes at 
4
o
C. Pellets were re-suspended in 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 20% glycerol, 
20 mM β-mercaptoethanol and 1 Complete Mini EDTA-free Protease Inhibitor Cocktail 
tablet. The sample was homogenized using a glass homogenizer and the cells were 
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disrupted by passing the sample twice through a French Press. Genomic DNA was 
sheared by applying the sample through a small syringe and the lysate was subsequently 
centrifuged at 17000g for 45 minutes at 4
o
C. All debris was discarded, while supernatant 
containing soluble histidine tagged protein was retained. 
The sample was applied to a column of Ni-NTA affinity resin (3 mL) and the 
column was washed with 300 mL of buffer containing 20 mM Tris-HCl (pH 8.0), 500 
mM NaCl, 20 mM imidazole and 20 mM β-mercaptoethanol to remove non-specific 
binding proteins. The desired AGT protein was eluted in 1 mL fractions with 20 mM 
Tris-HCl (pH8.0), 250 mM NaCl, 200 mM imidazole and 20 mM β-mercaptoethanol. 
Detection of protein present in each fraction was determined via a Bradfords reagent. All 
fractions containing protein were pooled and dialysed overnight in 2 L of buffer 
containing 50 mM Tris-HCl (pH 7.6), 250 mM NaCl, 10% glycerol, 5 mM DTT and 0.1 
mM EDTA. Protein concentration was determined using UV/vis spectroscopy and the 




 assuming all cysteine residues 
are reduced) was determined by the ProtParam tool on the ExPASy site. The pure protein 
was stored at -80
o
C. 
2.7 SDS-PAGE  
 SDS-PAGEs were performed on Biorad Mini-PROTEAN Tetra Cell system. 
Resolving mixture (5 mL) composed of 0.375 M Tris-HCl (pH 8.8), 0.1% SDS, 11.4% 
acrylamide, 0.6% bis-acrylamide, 25 μL 20% ammonium persulphate (APS) and 5 μL 
tetramethylethylenediamine (TEMED) was mixed and poured into the gel apparatus 
where it was allowed to polymerize. Ethanol was added on top to smooth out the 
polymerizing gel. Once polymerized, 2 mL of stacking solution containing 0.125 M Tris-
 26 | P a g e  
 
HCl (pH 6.8), 0.1% sodium dodecyl sulphate (SDS), 3.8% acrylamide, 0.2% bis-
acrylamide, 25 μL 20% APS and 5 μL TEMED was added. Samples, 20 μL, were 
prepared by mixing approximately 5 μg of protein, distilled water and 2X SDS-PAGE 
loading dye followed by boiling for 10 minutes. The 2X SDS-PAGE loading dye was 
composed of 0.06 M Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 0.025% bromophenol 
blue and 1.2 M β-mercaptoethanol. The gel was run at 120 V in glycine running buffer- 
0.025 M Tris-HCl (pH8.3), 0.192 M Glycine and 1% SDS- until the tracking dye almost 
migrates to the bottom. The gel was removed from the gel apparatus and incubated for 
about 30 minutes in staining solution, which consisted of 50% methanol, 10% acetic acid 
and 0.25% coomassie blue. The gel was subsequently destained in 50% methanol and 
10% acetic acid for 30 minutes or until optimally visualized. The gel was then cast in 
cellophane and left to dry. 
2.8 Protein mass spectrometry 
All protein samples were analysed using ESI-MS, where 25 µg of protein was 
precipitated using one volume of trichloroacetic acid (TCA) to four volumes of protein 
solution. The mixture was then incubated for 10 minutes on ice and subsequently 
centrifuged at 14000 rpm at 4
o
C for 5 minutes using a Sorvall Legend Micro 21R 
centrifuge. The supernatant was removed and the pellet washed with acetone several 
times to remove impurities. Residual acetone was removed by heating the sample in a 
sand bath at 60
o
C for 10 minutes. Once completely dry, the precipitate was dissolved in 
100 µL of distilled water and 100 µL of acetonitrile containing 0.1% formic acid. 
Samples were then analysed with a Waters Micromass Q-TOF-2 mass spectrometer 
operating in positive-ion mode. 
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2.9 Protein far UV circular dichroism spectroscopy 
Protein samples, approximately 5 µM, were buffer exchanged with 50 mM 
KH2PO4, 75 mM NaCl, 1 mM DTT, pH 7.5 buffer using Nanosep 3K Omega spin 
columns at 10,000 rpm at 4
o
C using a Sorvall Legend Micro 21R centrifuge. Circular 
dichroism spectra were obtained on a JASCO-810 spectropolarimeter using a 0.2 cm path 
length cell. The sensitivity was on standard mode, and the data pitch was 0.2 nm with a 
response time of 1 sec. The samples were measured from 260-200 nm with a scan speed 
of 20 nm/minute at a constant temperature of 20
o
C, maintained with a Pelletier 
temperature controller. The band width used was 1.0 nm and the scanning mode 
continuous. The data (the average of five accumulations) obtained was then smoothed 
and converted to molar ellipticity using software provided by JASCO 
87
.  
2.10 Protein thermal denaturation. 
 Protein samples were buffer exchanged exactly as those prepared for regular far 
UV circular dichroism spectra. Thermal denaturation was measured at 222 nm on a 
JASCO-810 spectropolarimeter using a 0.2 cm path length cell. The decrease of α-helical 
content as a function of increasing temperature was monitored at a rate of 20
o
C per hour 
between 20 to 90
o
C.  The data was then smoothed and plotted as percent folded as a 
function of temperature. The melting temperature (Tm) value was determined from the 
first derivative maxima of the thermal denaturation curves. 
2.11 Protein quantitation 
After protein dialysis, the absorbance of the pure protein sample was determined 
at 280 nm using a Varian Cary3000 Bio UV-visible Spectrophotometer, with the dialysis 
buffer as the blank. The absorbance observed was used to calculate the protein 
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 assuming all cysteine residues are reduced) calculated by the 
ProtParam program on the ExPASy site.  
A secondary protein quantitation method (Bradfords assay) was employed to 
confirm the concentration of samples with volumes less than 1 mL. A 10 μL protein 
sample was incubated with 1000 μL of Bradfords reagent to a total of 1100 μL solution at 
room temperature for 10 minutes. Absorbance was measured at 595 nm and compared to 
a standard curve previously prepared using BSA protein at various concentrations.  
2.12 DNA solid-phase synthesis 
 Solid-phase synthesis (SPS) was performed on an Applied Biosystems 3400 DNA 
synthesizer using cyanoethyl-N,N-diisopropyl-phosphoramidites (phosphoramidites) as 
per standard protocols
88-90
. Unlike biological systems, oligonucleotide solid-phase 
synthesis is typically performed in a 3’ to 5’ direction. SPS is an efficient and simple 
method to quantitatively synthesize short DNA sequences. 
 All control DNA from either the bi-partite or tri-partite projects- unmodified and 
those containing pyrrolo-dC (procured from Glen Research)- were synthesized using long 
chain alkylamine (lcaa) controlled pore glass (CPG) solid support on a 1 μmole scale, 
whereas ICL and O
6
-methyl-dG modified DNA were prepared using polystyrene solid 
support on a 2 μmole scale (see Table 3 for complete list of sequences).  All 3’-
phosphoramidites, containing standard protecting groups, were purchased from Glen 
Research. Furthermore, 3’-amidites were diluted to 0.1 M in 100% acetonitrile (ACN), 
while 5’-amidites from ChemGenes Inc. were diluted to 0.2 M in 100%ACN.  
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Synthesis was conducted under the following cycle parameters, with an ACN 
wash in between each step: (1) detritylation with 3.0% TCA in dichloromethane (DCM) 
for 120 seconds; (2) coupling with ethyl thiotetrazole as activator for 120 seconds for 3’-
phosphoramidites or 180 seconds for 5’-phosphoramidites or 600 seconds for pyrrolo-dC 




-dG amidites (0.15 M, prepared by Dr. Christopher 
Wilds); (3) oxidation with 0.02 M iodine in THF-water-pyridine (2.5:2:1, v/v/v); (4) 
capping of uncoupled oligonucleotides with 1:1 (v/v) acetic anhydride-2,6-lutidine-
tetrahydrofuran (THF) (1:1:8, v/v/v, solution A) for control sequences or 1:1 (v/v) 
phenoxyacetyl anhydride-2,6-lutidine-THF (1:1:8, v/v/v, solution A) for ICL or O
6
-
methyl-dG DNA with 1-methyl-1-H-imidazole-THF (16:84, w/v, solution B). The cycle 
was repeated until the desired oligonucleotide sequence was completed and finally 
detritylated. The oligonucleotide extension in the ICL synthesis varied, in that additional 
on column deprotection to remove allyloxycarbonyl (alloc) and/or silyl protecting groups 
was required prior to completion of the final desired oligonucleotide product (see section 
2.13 and 2.14 following). Once synthesis was complete, the DNA was ready for cleavage 
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Table 3 List of sequences prepared using SPS for both bi-partite and tri-partite projects. 




-dG modification; C designates a substitution of 




2.13 De-alloc reaction 
 Removal of the allyloxycarbonyl (alloc) group was performed on the solid 
support. Treatment began with overnight incubation with triethylamine (TEA), followed 
by washing with 20-30 mL THF and 20 mL 100% ACN, and subsequent drying by high 
Bi-partite project 
Code name Oligonucleotide sequence (5'-3') Modification 
CJW322 GAG TAG ACT ACT C None 
CJW323 GAG TAG TCT ACT C None 
CJW324 GAG TAG ACT ACT C pyrrolo-dC (C) 
CJW325 GAG TAG ACT ACT C pyrrolo-dC (C) 
CJW326 ICL DNA 
(ICLpyrrolo1) 
GAG TAX ACT ACT C 







CJW327 ICL DNA 
(ICLpyrrolo2) 
GAG TAX ACT ACT C 







CJW328 ICL DNA 
(ICL) 
GAG TAX ACT ACT C 







Tri-partite project (5'-3') 
Code name Oligonucleotide sequence (5'-3') Modification 
CJW239 GCA TGA CTA GTC GTG CTG CT None 
CJW243 AGA CGC ACG ACT AGT CAT GC None 
CJW269 GAT CAC TGA CTA CGC TAC None 
CJW270 GTA GCG TAG TCA GTG ATC None 
CJW271 GTA GCG TAG* TCA GTG ATC O
6
-methyl-dG 
CJW272 GAT CAC TGA CTA CGC TAC pyrrolo-dC 
CJW273 GAT CAC TGA CTA CGC TAC pyrrolo-dC 
CJW274 GAT CAC TGA CTA CGC TAC pyrrolo-dC 
CJW293 ICL DNA GTA GCG TAX TCA GTG ATC 







CJW294 ICL DNA GTA GCG TAX TCA GTG ATC 







CJW295 ICL DNA GTA GCG TAX TCA GTG ATC 
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vacuum. Once dry, the sample was transferred to a glass vial and incubated with 
palladium tetrakis-triphenylphosphine (0.0029 g, 10 eq.), triphenylphosphine (0.0013 g, 
20 eq.) and 0.25 mL of buffer solution comprised of butyl amine (100 eq.) and formic 
acid (100 eq.) at 35°C for 3 hours; mixing every 30 minutes. The mixture was then 
transferred to a clean column for solid phase synthesis and was washed with 20-30 mL 
THF and 20 mL ACN and dried by high vacuum. Upon complete dryness, the column 
was treated with a palladium scavenger, N,N-diethyldithio-carbamate saturated in 3 mL 
ACN, for 30 minutes and re-treated until no yellow colour was present. The scavenger 
step limited the possibility of prolonged exposure to palladium that may lead to possible 
strand breakage. The column was washed again with 20-30 mL THF and 20 mL ACN 
and dried by high vacuum, after which it was ready for solid-phase synthesis extension. 
2.14 De-silylation reaction 
 The silyl protecting group, tert-butyldimethylsilyl (TBS), was removed while the 
oligonucleotide was on the solid support at room temperature. First, the sample was 
treated with 1-2 mL TEA overnight to remove cyanoethyl groups, making the phosphate 
backbone less prone to nucleophilic attack and strand breakage. The column was later 
washed with 20-30 mL THF and 20 mL ACN and dried by high vacuum for 20 minutes. 
Once dry, 1 mL of TEA/HF (1:3) was applied and was left incubating for 1 hour with 
periodic mixing. Sample was then washed with 20-30 mL THF and 20 mL ACN and 
dried by high vacuum; ready to extend using solid-phase synthesis. 
2.15 DNA deprotection 
 Deprotection of unmodified oligonucleotides containing the most common 
protecting groups (benzoyl, isobutyryl, 2-cyanoethyl and 4-isopropylphenoxyacetyl (i-Pr-
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PAC)) typically involves incubation at 55°C for 4 hours in 500μL ammonia/ethanol (3:1). 
However, due to the presence of pyrrolo-dC, milder conditions were used for all DNA 
samples. Oligonucleotides on the solid support were transferred to a 2 mL screw-cap tube 
and incubated at room temperature over 36-48 hours in the dark in 500 μL 
ammonia/ethanol (3:1). Once deprotection was complete, supernatant was extracted and 
the solid support washed twice with 50% ACN, all of which was pooled and dried down 
for further analysis. 
2.16 DNA quantitation 
 DNA quantitation was performed using absorbance detection at 260nm with a 
Varian Cary300 Bio UV-visible Spectrophotometer. 18 Mohm water was present in the 
reference cell and the instrument blanked with 18 Mohm water. DNA samples were 
diluted in 1 mL 18Mohm water and the absorbance/optical density (OD) was measured, 
providing a concentration of OD/μL. Quantitation was performed for crude samples, 
desalted samples and pure samples. The OD/μL concentration can be converted to a μM 
value by using Beer-lambert’s Law and a calculated extinction coefficient (tri-partite 








  for 













  for complement strand 
with and without O
6




 for dsDNA), which was 
determined using OligoAnalyzer for single stranded DNA and IDT Biophysics for double 
stranded DNA. It must be noted that the molar extinction coefficients for ICL DNA, O
6
-
methyl-dG and pyrrolo-dC are not exact values, because the extinction coefficient of the 
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modified base is not always known, and hence only approximations of the μM 
concentrations can be made. 
2.17 DNA purification 
 A 40mL 20% polyacrylamide gel solution of 19:1 (w/w) acrylamide: bis-
acrylamide (UltraPure and BioUltraPure grade respectively, Bioshop), 1X TBE-  
5.45wt% (w/v) Tris-HCl, 2.75wt% (w/v) boric acid, 0.186wt% (w/v) EDTA (ACS grade, 
Fisher Scientific) in distilled water- and 7M urea (UltraPure molecular biology grade, 
Bioshop) was mixed with 100 µL 20wt% (w/v) APS and 100µL TEMED and allowed to 
polymerize for 30 minutes. Once the gel was polymerized and wells washed with 1X 
TBE buffer, approximately 20-40 ODs of DNA was dissolved in 100 μL of formamide, 
loaded into the well and the gel was performed in 1X TBE buffer with a SE600X chroma 
deluxe dual cooled vertical Hoefer unit with a power maximum at 10 W for 3-3.5 hours 
or 4-5 hours for better resolution of DNA products. Migration was monitored with 6X 
denaturing loading dye- 0.001wt% (w/v) bromophenol blue (ACS Fisher Scientific) and 
0.001wt% (w/v) xylene cyanol (Bioshop) dissolved in formamide. Upon completion, the 
gel was removed from the apparatus, visualized under UV light and the desired band was 
excised. DNA was extracted from the gel by incubating the gel bands in 10 mL 0.1 M 
sodium acetate (Sigma Aldrich) in the dark, while shaking at room temperature for 
approximately 16 hours.  
2.18 DNA desalting 
 DNA extracted from gels contains a high concentration of salts, which needed to 
be removed prior to biophysical analysis of the DNA. A Sep-Pak
®
 C-18 cartridge 
(Waters) was equilibrated by applying 5 mL 100% ACN, followed by 8 mL 50% ACN 
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and finally flowing through 10 mL 0.1M sodium acetate. The cartridge was never 
allowed to dry. Quantitation of the DNA extract was performed and then passed twice 
through the cartridge at a drop-wise flow rate. Once the DNA was adsorbed to the C-18 
cartridge, it is washed with 20-30 mL 18 Mohm water to remove residual salt. Once the 
flow-through was void of salt, the DNA was eluted with 3-4 mL of 1:2:1 (v/v/v) 100% 
ACN: 100% methanol: 18 Mohm water into a 5 mL screw cap tube and later dried down 
by speed vacuum, re-suspended in water and quantitated to determine overall yield and 
concentration of stock samples. 
2.19 DNA HPLC analysis 
 Two forms of HPLC stationary phases were used: Reverse phase (RP) and ion 
exchange (IEX). Before use of the HPLC instrument, the lines were primed and cleared 
of the storage solution (50% methanol for RP or 10% methanol for IEX). Analytical IEX-




 PA-100 column using a gradient 
from 0-0.5 M NaCl in a buffer of 0.1 M Tris-HCl (pH 7.8) and 10% ACN at a flow rate 
of 1 mL/minute for 45 minutes with a loading volume of 500 μL containing 0.1-0.5 ODs 
of DNA in 18 Mohm water for analytical runs with a detection wavelengths of 260 nm 
and 280 nm. RP-HPLC was used to analyse DNA composition and monitoring removal 
of TBS protecting groups. A 500 μL sample of approximately 0.1 OD of DNA was 
loaded on a Water Symmetry
®
 C-18 5 μm column and analyzed with a gradient from 0-
45% ACN in a 50 mM sodium phosphate buffer (pH 5.8) at a flow rate of 1 mL/minute 
for 45 minutes.  
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2.20 DNA nuclease digestion and compositional analysis 
 Approximately 0.1OD of a pure DNA sample was dried down and incubated with 
0.5 μL snake venom phosphodiesterase I (SVP) (P-L Biochemicals Inc.) and 0.5 μL calf 
intestinal alkaline phosphatase (CIAP) (Fermentas Life Sciences) in 19 μL of SVP buffer 
(10 mM Tris-HCl (pH 8.1) and 2 mM MgCl2) at 37°C overnight or 48 hours for ICL 
DNA. Half of the digested sample was then diluted to 500 μL with 18 Mohm water and 
analyzed by RP-HPLC. The ratios of the areas for the nucleoside peaks divided by the 
respective extinction coefficients were used to determine the nucleotide composition of 
the oligomers. 
2.21 DNA thermal denaturation  
 DNA thermal denaturation was conducted on a Varian Cary300 Bio UV-visible 
Spectrophotometer using a Cary temperature controller. DNA samples, dried down from 
stock solutions, were re-suspended in 1 mL Tm buffer (90 mM NaCl, 10 mM sodium 
phosphate (pH 7.0), and 1 mM EDTA) to a concentration of approximately 2.4 μM for 
ICL or unmodified duplexes. The sample was heated to 90°C for 10 minutes, cooled at 
4°C to anneal the DNA overnight and transferred to a 1 cm quartz cuvette for analysis. 
The increase in absorbance with increasing temperature was measured from 15-95°C with 
a 0.5°C increment over 1 hour. The observed thermal denaturation curves were 
normalized to increasing hyperchromicity and the Tm value was obtained via the first 
derivative maxima. 
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2.22 DNA far-UV circular dichroism spectroscopy 
 DNA CD spectra were obtained on a JASCO-810 spectropolarimeter using a 1cm 
path length cell, with approximately 2.4 μM DNA sample in 1 mL Tm buffer (90 mM 
NaCl, 10 mM sodium phosphate (pH 7.0), and 1mM EDTA). The sensitivity was on 
standard mode, and the data pitch was 0.2 nm with a response time of 1 sec. The samples 
were analyzed from 340-200 nm with a scan speed of 20 nm/minute at a constant 
temperature of 20
o
C, maintained with a Pelletier temperature controller. The band width 
used was 1.0 nm and the scanning mode continuous. The data (the average of five 
accumulations) obtained was then smoothed and converted to molar ellipticity using the 
software provided by JASCO
91-93
. 
2.23 Radioactivity labelling assay 
 DNA samples were radioactively labelled by incubating 10-100 pmol of DNA 
(depending if it was for repair or binding assays) with 10X polynucleotide kinase (PNK) 
buffer, 1.0 μL ɣ-32P ATP (6000 Ci/mmol, Perkin Elmer) and 0.5-1.0 μL  T4 PNK 
(Fermentas Life Sciences) at 37°C for 1 hour. Samples were then boiled for 5-10 minutes 
to denature the PNK. Once the ssDNA was labelled, it was incubated with 1.05 times of 
its complementary strand to ensure near complete incorporation of the labelled strand into 
dsDNA. Labelled DNA prepared for binding assays were diluted to a 1 mL solution using 
a salt binding buffer (10 mM Tris-HCl (pH 7.6), 100 mM NaCl, 1 mM DTT, 200 μg/mL 
BSA and 50% glycerol in water).  
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2.24 Radioactivity repair assay 
 Overnight repair analysis was conducted with 60 pmol protein, 2 pmol of DNA 
and 6.67 mM EDTA in an activity buffer of 50 mM Tris-HCl (pH 7.6), 100 mM NaCl 
and 5 mM DTT solution at 37°C. Time course assays were conducted using 600 pmol 
protein, 12 pmol of DNA and 6.67 mM EDTA in activity buffer over 120 minutes at 
37°C, with samples collected at various times (minutes): 0, 5, 15, 30, 45, 60, 75, 90, 105 
and 120. At each time point, the reaction was terminated with the addition of a solution 
containing 1%SDS, 72% formamide, 0.9X TBE, 0.001wt% (w/v) bromophenol blue and 
0.001wt% (w/v) xylene cyanol- and the sample boiled to denature the repair protein. 
Samples were then analyzed on a 20% polyacrylamide gel. The solution was prepared as 
a 19:1 (w/w) acrylamide: bis-acrylamide and 7 M urea mixture dissolved in 1X TBE 
(5.45wt% (w/v) Tris-HCl, 2.75wt% (w/v) boric acid, 0.186wt% (w/v) EDTA in distilled 
water), and polymerized using 100 µL 20wt% (w/v) APS and 100 µL TEMED. Gels were 
imaged and a radioactivity count was obtained using a PhosphorImager TyphoonTrio 
instrument. 
2.25 Radioactivity binding assay 
Protein concentrations were varied below and above the predicted dissociation 
constant (Kmonomeric) and were incubated with 0.5 nM DNA in activity buffer (50 mM 
Tris-HCl (pH 7.6), 100 mM NaCl and 5 mM DTT) at room temperature for 20 minutes. 
Samples were then applied to a polymerized 15% native polyacrylamide gel composed of 
75:1 (w/w) acrylamide: bis-acrylamide in 0.5X TBE. The polyacrylamide gels were 
performed at 250 V in 0.5X TBE for 25 minutes. Gels were imaged and a radioactivity 
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count was determined using a PhosphorImager TyphoonTrio instrument. Kd’s and 
Kmonomeric’s were obtained using a modified Hill Plot of the data and repeated in duplicate. 
The following is the calculations involved to determine the dissociation constants 
of a given data set plotted in a modified Hill plot
94, 95
: 
Dissociation of protein (E) and substrate (S) from the protein-substrate 
complex (ES) can be defined as: 
EnS ↔ nE + S 
Where n represents cooperativity and Kd is representative of the overall 
binding constant. The overall dissociation constant (Kd), where we cannot 
measure intermediates, can be defined as: 
Kd  = [E]
n
 [S]/[EnS] 
Certain approximations and assumptions are made based on experimental 
protocol: 
(1) [S] <<<< [Etotal] 
(2) [ES] <<<< [Etotal] 
(3) [E]= [Etotal] – [ES] ≈ [Etotal]; since [ES] <<<< [Etotal] 
(4)  Therefore, Kd = [E]([S]/[ES]) ≈ [E] ≈ [Etotal] 
(5) [S] ≈ [ES] when [Etotal] = Kd 
The Kd equation can be manipulated such that the n is no longer an 
exponent: 







) + log([S]/[EnS]) 
log(Kd) - log([E]
n
) = log([S]/[EnS]) 
log(Kd) - nlog([E]) = log([S]/[EnS]) 
-log(Kd) + nlog([E]) = log([EnS]/ [S]) 
From the boxed equation we can designate log[E] as the x variable and 
log([EnS]/ [S]) as the y-variable and n is the slope. As such we can then 
plot the data obtained as log([EnS]/ [S]) against log([Etotal]) where the y-
intercept is the -log(Kd). The boxed equation can then be simplified to the 
following equation: 
y = nx - log(Kd) 
y-intercept = - log(Kd) 
Kd = 10^
- log(Kd)  
 
  As an example the following equation will be used as seen in Figure 34:
 
y = 1.8644x + 0.2409 (R
2
 = 0.991) 




Kd = 0.5742 
 40 | P a g e  
 
2.26 Fluorescence binding assay 
Fluorescence binding assays were conducted using 391 nM DNA and 0-7 μM 
protein in 6.67 mM EDTA and activity buffer (50 mM Tris-HCl (pH 7.6), 100 mM NaCl 
and 5 mM DTT) in a volume of 600 μL (a modified protocol from Zhang et al 200555). 
Samples were equilibrated for 30 minutes and fluorescence was subsequently monitored 
in a 10 mm quartz cuvette using a Varian Cary Eclipse Fluorescence Spectrophotometer 
at 25
o
C. Spectra were observed under the following parameters: Excitation at 346 nm 
with a slit width of 10nm, emission from 400-600 nm with a slit width of 5 nm, medium 
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Chapter 3: Results and discussion 
3.1 Protein characterization 
3.1.1 General Outline 
 In order to study binding and repair of ICL DNA several AGT variants were 
investigated. AGT variants cysteine 145 to serine (C145S) and arginine 128 to alanine 
(R128A) were developed from AGT wild type plasmids using site-directed mutagenesis 
(see section 2.2). The C145S variant, an inactive variant that is unable to repair damaged 
DNA, was prepared as a standard for binding assays. R128A variant was prepared to 
observe the importance of the arginine ―finger‖ in repairing and binding of ICL DNA. A 
control AGT homolog, Ada-C, was employed as it is well known that it cannot repair 
ICL DNA, but its binding mode may aid in understanding AGT-ICL association. All 
proteins were purified as is indicated in section 2.6.  Once purified, proteins underwent 
several biophysical techniques that are required for identification, monitoring stability 
and changes in secondary structure. 
3.1.2 Mass spectrometry 
 Identification of AGT wild type, C145S, R128A and Ada-C was verified using 
Waters Micromass Q-TOF-2 mass spectrometer (see section 2.8). Experimentally 
determined masses were compared to calculated masses based on the ProtParam tool on 
the ExPASy site (see Table 4). All experimental masses correlated closely to the 
expected masses with AGT wild type, C145S, R128A and Ada-C having mass 
differences of 1.2Da, 2.5Da, 0.4Da and 1.4Da respectively. Identity was further 
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confirmed by analysis of purified proteins using SDS-PAGE gel electrophoresis (see 
Figure 15). 
Proteins Expected mass (Daltons) Observed mass (Daltons) 
hAGT wild type 21876.2 21875.0 
C145S 21860.1 21862.6 
R128A 21791.0 21789.6 
Ada-C (E.coli homolog) 20709.5 20708.1 
Table 4 MS analysis results of AGT variants, comparing expected against observed 
masses. 
 The observed and calculated masses correlate well confirming the identity of each 
AGT variant. There were peaks of greater mass observed, with mass increases of 
approximately 23Da, which is representative of sodium ions that are bound to the protein. 
 
Figure 15 SDS-PAGE analysis of purified proteins wild type AGT (lane B), C145S (lane 
C), R128A (lane D) and Ada-C (lane E) with a low molecular weight marker (lane A).  
3.1.3 Structural analysis comparison and stability 
 Far-UV circular dichroism was used to compare differences in secondary 
structure and stability between the AGT variants. Using mean residue ellipticity, we can 
compare the CD signal observed for proteins of differing number of amino acids of 
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varying concentration. We observed an increase in CD signal for R128A mutant and 
Ada-C homologs. In addition, there appears to be a minor loss of CD signal for C145S 
(see Figure 16). It must be noted that although there are some differences between AGT 
(207 amino acids) and its human variants, the shape of the curve remains very similar, 
suggesting similar conformation. Ada-C, E. coli homolog (188 amino acids), shows 
significant difference in CD signal as compared to AGT. It must be noted that circular 
dichroism is used as a comparative tool in this instance, and as such only AGT and its 
variants (C145S and R128A) can be compared. However, we can say that all proteins are 
clearly showing secondary structure and are therefore folded and stable at room 
temperature in the buffer system. 
 
Figure 16 Far-UV CD signal of AGT variants. 
 In addition to comparing secondary structure signal, we can determine the relative 
stability of a protein based on thermal denaturation studies. CD signal was measured at 




































 44 | P a g e  
 
over time. This allows us to monitor the effect a mutation may have on the stability of the 
protein variant. We observed a significant difference in stabilities due to single point 
mutations. Among the AGT human variants we determined that C145S showed the 
lowest stability with a Tm of 55.2
o
C, followed by AGT wild type with a Tm of 59.0
o
C and 
the most thermally stable protein was R128A with a Tm of 62.2
o
C (see Figure 17). Ada-C 
showed the lowest overall thermal stability with a Tm of 49.2
o
C; however this only 
represents a fraction of unfolded protein (approximately 60%).  
 
Figure 17 Thermal denaturation studies of AGT and its variants, normalized to fraction 
unfolded. 
3.1.4 Summary 
 AGT proteins were purified and clearly identified using MS Q-TOF. In addition, 
all proteins show a folded state in the buffer systems used, with thermal stability studies 
showing all proteins to be stable for repair and binding assay conditions (37
o

























hAGT wt   59.0°C
C145S      55.2°C
R128A      62.2°C
Ada-C       49.2°C
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completion of characterization of the AGT wild type and variants, we could begin to 
characterize the DNA substrates, bringing us closer to binding and repair assays.  
3.2 Preparation of ICL DNA probes 
3.2.1 Tri-partite DNA 
3.2.1.1 General 





-2’-deoxyguanosine (O6-dG-heptylene-O6-dG) crosslink was centrally 
positioned and in a 5’-GNC-3’ motif. In addition, an oligonucleotide containing an 
asymmetrical diverse base composition was chosen to simulate the environment of 
genomic DNA. Although, cut-sites are often included to observe repair of mono-adducts, 
no such sites were incorporated into the ICL DNA as repair could be easily monitored 
using PAGE gels because there is a major shift in band migration when comparing 
repaired ssDNA and ICL DNA. Furthermore cut-sites increased symmetry resulting in 
possible undesired hairpin formation. The sequence also took into consideration specific 
placement of dC residues that could be replaced with a pyrrolo-dC fluorescent analog, 
with sites positioned centrally and near the 5’-end. In order to incorporate 3 sites for 
pyrrolo-dC insertion, a relatively long oligonucleotide was desired (18 bases ssDNA and 
36 bases dsDNA). However if the DNA sequence was too long, yields for ICL DNA 
would be decreased as compared to synthesis of a shorter sequence, and the ability to 
form competing hairpin structures also increases.  
For intermediates A, B, C and D (see Figure 19), it was necessary to introduce a 
protective group that could be retained under conditions to remove the 5’-OTBS and 3’-
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OAlloc groups in order to avoid undesired chain extension during solid phase synthesis, 
avoiding various oligonucleotide side products (see Figure 18 bottom graph). The 
protective group chosen was levulenyl (Lev), which was resistant to F
-
 and palladium 
treatment. This group was introduced using 3’-deoxyphosphoramidites containing a 5’-
Olev protecting group. Initial attempts used 5’-OLev-dG and 5’-OLev-dT, which failed 
due to the mixture of levunilated and non-levunilated amidites (see Figure 18 top 
graph), where 100% coupling of the crosslinked amidite and no mixture of Lev amidites 
would result in one peak. Through optimization we were able to determine that 5’-OLev-
dC was able to cap the 5’-ends and avoid extension. All ICL DNA were synthesized, 
purified and biophysically analyzed to reveal purity, structure and stability.  
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Figure 18 IEX-HPLC analysis of T-form ICL DNA after treatment with TEA/HF for 
TBS deprotection (top), with the two major peaks representative of the coupling of 
levulinyl containing dG amidite, and analysis of H-form ICL DNA with the desired 
product situated within the large broad peak (bottom). 
3.2.1.2 ICL DNA Synthesis 
 Controls were synthesized with high yields and well behaved, and hence will not 
be discussed in this section. The major issue with ICL DNA synthesis was step (ii) 
(coupling of dG-dG amidite, see Figure 19). Initially coupling was as poor as 10%, 
resulting in extremely low yield of final product. Extra purification of the amidite was 
conducted to ensure an extra pure sample. Due to the scarcity of the crosslink amidite we 
were unable to attempt synthesis with a higher concentration. However, extra dry 
reagents, increased coupling time and a highly pure amidite were used to improve 
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coupling. Unfortunately coupling was only able to improve to a maximum of 50% 
resulting in relatively low overall yields of ICL DNA. It is possible that due to the 
amount of protecting groups and the bulky crosslinked dG group that steric clashing 
could have reduced coupling yield. 
 
Figure 19 ICL DNA synthesis scheme, with X, Y and Z designating possible sites of 
incorporation of pyrrolo-dC, where X, Y, Z= dC for wild type, X, Y= dC and Z= pyrrolo-
dC for sequence CJW293, X, Z= dC and Y= pyrrolo-dC for sequence CJW294, and Y, 
Z= dC and X= pyrrolo-dC for sequence CJW295. Steps: (i) extension to the core, (ii) ICL 
amidite coupling, (iii) extension to the T-form, (iv) deprotection of the silyl group TBS, 
(v) extension to the Y-form, (vi) deprotection of the alloc group, (vii) extension using 5’-
amidites to the final H-form DNA and (viii) deprotection from solid support and all 
protecting groups with ammonia/ethanol. 
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3.2.1.3 Purification 
 ICL DNA purification was performed using polyacrylamide gels. Surprisingly 
two major peaks were observed which shall be referred to as top and bottom bands, while 
the lowest band is representative of the ―core‖ that did not couple with the dG-dG amidite 
(see Figure 20). Interestingly, the top band is not detectable under normal IEX-HPLC 
conditions and does not co-elute with the bottom band which is detectable, hence 
purification by gel. The top and bottom bands were excised for further analysis, because 
unlike simple DNA synthesis the upper most bands are not necessarily the desired 
product due to the size of the DNA and the complexity of its synthesis. The reason for the 
two major products is unclear, as the shift is more than one uncoupled base and yet they 
also migrate too closely for one to be the Y-form over the H-form of DNA. It was also 
postulated that perhaps due to its size it was able to form two overall distinct secondary 
structures that resulted in two bands. However, an analytical polyacrylamide gel was 
attempted with denatured and renatured ICL DNA strands with little success, as the same 
shift in band migration was observed. Isolated yields ranged from 6-10% and further 
biophysical analysis was completed to discover the true identity of the top and bottom 
bands. 
 50 | P a g e  
 
 
Figure 20 Polyacrylamide purification gel of ICL DNA with the desired product as either 
the top or bottom bands as designated, where the lowest band is designated as core DNA 
that did not couple with the crosslinked amidite.  
3.2.1.4 DNA nucleoside composition 
 Nuclease digestion and subsequent RP-HPLC analysis was used to observe if the 
nucleoside ratios agreed to expected values and more importantly the presence of the 
desired pyrrolo-dC and crosslinked nucelosides (at approximately 22 minutes). DNA 
composition analysis showed similar nucleoside ratios for all ICL DNA of both top and 
bottom bands.  In addition, pyrrolo-dC did not appear in DNA composition analyses 
when it should have been present in ICL DNA (see Figure 21). This presented two 
problems, why was pyrrolo-dC not appearing and was there some other characterization 
method that could identify the desired product. Firstly, pyrrolo-dC not appearing could be 
due to possible breakdown during ICL DNA synthesis, most likely at either the 
deprotection of TBS or alloc groups. However, based on the bi-partite project pyrrolo-dC 
is stable under the de-silylation conditions (see Section 3.2.2). It is uncertain if the 
deprotection of alloc caused a breakdown of the pyrrolo-dC base; more analysis is 
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required. Secondly, MS technique LTQ Orbitrap Velos was considered as a method of 
characterization. However, due to the size of the ICL DNA we were unable to determine 
a mass, where we were able to determine the mass of smaller dsDNA or ssDNA 
molecules. Nucleoside DNA composition analysis did not aid in discriminating the 
identity of either the top or bottom bands. It was then believed that thermal denaturation 
and possibly CD could help to elucidate the identities of ICL DNA top and bottom bands. 
 
Figure 21 ICL DNA composition analysis. All ICL DNA (top and bottom bands) with 
and without pyrrolo-dC showed similar ratios. 
3.2.2 Bi-partite DNA 
3.2.2.1 General 
 Being unable to have a fully characterized tri-partite ICL DNA, we decided to 
design a bi-partite ICL DNA sequence. This new shorter oligonucleotide retained the 







-dG) crosslink that was centrally positioned, with 
only two pyrrolo-dC incorporation sites. Furthermore, the base composition was modified 
to become symmetrical, except at the 5’-GNC-3’ motif. This simpler bi-partite synthesis 
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did not require levulenyl capping at the 5’-end. All ICL DNA were synthesized, purified 
and biophysically analyzed to reveal purity, structure and stability. 
3.2.2.2 ICL DNA Synthesis 
 ICL DNA and controls were synthesized as described in section 2.12. Control 
DNA synthesis was straightforward with all oligonucleotides purified by gel and 
characterized, and hence will not be covered in this section. ICL DNA synthesis was 
completed in several stages as is outlined in Figure 22 with steps (i) to (v). The steps that 
proved most difficult due to poor coupling yield were steps (ii) and (v). Step (ii) is the 




-dG amidite with what we refer to as the 
core of the ICL DNA. Coupling tended to be initially low, however, with extra 
purification of the amidite (completed by Dr. C. Wilds) coupled with use of extra dry 
reagents and longer coupling time we were able to increase coupling yields as impurities 
and moisture could react with the prepared amidite Coupling was improved to above 
90%.  
Step (v) involves the use of 5’-amidites, which usually require longer coupling 
time than regular 3’-amidites. However, even with increased time there appeared to be 
poor coupling during extension resulting in increased amount of side products. We 
attempted to increase coupling with a higher concentration of 5’-amidite, dry reagents 
and a 30 second increase in coupling time, yet little improvement was observed. It is 
unclear why the 5’-amidites did not couple at 90% and higher, yet it appears that it could 
be sequence dependent as poor coupling tended to occur only with the sequences 
highlighted in this project, but not in other oligonucleotides with differing sequences (not 
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shown). 5’-amidite coupling could also be hampered due to the steric hindrance of the 
opposing arm of DNA that could potentially block the coupling site. 
 
Figure 22 Synthesis scheme of ICL DNA, where X designates positions of pyrrolo-dC 
incorporation, where X, Y= dC for wild type CJW328, X= dC and Y= pyrrolo-dC for 
sequence CJW326 (ICL pyrrolo1), and Y= dC and X= pyrrolo-dC for sequence CJW327 
(ICLpyrrolo2). Steps: (i) extension to the core, (ii) ICL amidite coupling, (iii) extension 
to the Y-form, (iv) deprotection of the silyl group TBS, (v) extension using 5’-amidites to 
the final H-form DNA and (vi) deprotection from solid support and all protecting groups 
with ammonia/ethanol. 
3.2.2.3 De-silylation reaction  
An intermediate step of ICL DNA synthesis was the removal of a silyl group on 
the 5’-end of the dG-heptylene-dG group. Removal of the tert-butyldimethyl silyl group 
(TBS) was monitored using HPLC. First batch of ICL DNA used RP-HPLC to observe 
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TBS removal, while IEX-HPLC was used in the analysis of the second batch of ICL 
DNA synthesis.  
 
Figure 23 RP-HPLC chromatograms of oligonucleotides of ICLpyrrolo1 DNA in the 
presence of TBS protecting group and after the treatment with TEA/HF to remove TBS.  
RP-HPLC chromatograms showed a clear shift in peak from 13.11 minutes to 
9.71 minutes (see Figure 23) after treatment with TEA/HF to remove the TBS group. 
This was consistent for all 3 ICL DNAs: ICL, ICLpyrrolo1 and ICLpyrrolo2. Due to the 
consistent shift in peak we believed this confirmed TBS removal. In addition, the 
decrease in retention time upon TBS removal is expected as TBS increases the 
hydrophobicity of the oligonucleotide.  IEX-HPLC chromatograms, on the other hand, 
displayed a minor shift in peak elution time in samples with and without TBS (see Figure 
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24). Although the shift was minor (0.6 minute difference), which is not unexpected as 
retention times will not greatly increase or decrease with the removal of one TBS group 
per ICL molecule as the association between the analyte and the stationary phase is 
primarily based upon ionic interactions. The change was consistent for all ICL samples.  
 
Figure 24 IEX-HPLC chromatograms of oligonucleotides of ICLpyrrolo1 DNA in the 
presence of TBS protecting group and after the treatment with TEA/HF to remove TBS. 
3.2.2.4 Purification 
 Upon completion of ICL DNA synthesis and subsequent deprotection the samples 
were analyzed by IEX-HPLC to evaluate the overall efficiency of the synthesis. HPLC 
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analysis on an analytical scale yields information regarding the overall synthesis and 
whether modifications to the HPLC conditions (buffer, gradient etc.) must be made. The 
IEX-HPLC chromatograms revealed the presence of by-products (see Figure 25).  Thus 
this method could not be used for initial purification because of the close proximity of 
highly abundant side-products and the challenge in separating them as in preparation runs 
the amount of sample loaded is increased 30 fold, resulting in peak broadening and 
overlap. Fortunately, analysis by PAGE of the crude demonstrated improved resolution 
of the products. Thus the oligonucleotides were purified by gel electrophoresis.  
 
Figure 25 Comparison of IEX-HPLC analytical analysis of crude ICL DNA sample (A) 
and 20% polyacrylamide purification gel (B). The final product or H-form of the ICL 
DNA is designated by the arrows. 
After purification by PAGE and desalting the ICL DNA samples were analyzed 
by HPLC. The chromatograms (see Figure 26) indicated the presence of impurities that 
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eluted slightly before and after the desired product. Additional purification was attempted 
with a pH12.5 buffer, however, it has not yet been confirmed if the crosslink was 
unaffected. Furthermore, multiple attempts at improving overall synthesis did not 
significantly reduce by-product impurities, resulting in the constant presence of minor 
impurities. Moreover, yields purified were low, ranging from 11.7%-23.3%, making a 
second round of purification to all samples problematic due to the need for relatively high 
amounts of DNA sample (391 nM DNA/600 μL sample) needed for fluorescent binding 
studies.  
 
Figure 26 Comparison of IEX-HPLC analytical analysis of crude ICL DNA sample (top) 
and analytical analysis of pure ICL DNA sample (bottom).  
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3.2.2.5 DNA nucleoside composition 
 Verification of the presence of the crosslink and pyrrolo-dC nucleosides, in 
addition to the overall nucleoside content, was verified by nuclease digest and by RP-
HPLC analysis. In addition to the natural four nucleosides, the digests of the sequences 
displayed the presence of both pyrrolo-dC and dG-heptylene-dG crosslinked nucleosides 
with peaks at approximately 10.5 and 22 minutes respectively (see Figure 27). The 
absence of additional species suggests the fluorescent base analog pyrrolo-dC showed 
chemical stability under DNA synthesis and deprotection conditions used for ICL DNA 
synthesis. The digest data for all ICL sequences revealed they contained the correct 
nucleoside composition with good agreement between the expected and observed ratios. 
All linear sequences that were synthesized were also found to have the correct nucleoside 
composition and the presence of an additional nucleoside corresponding to pyrrolo-dC 
(not shown). 
 
Figure 27 DNA composition of ICL DNA containing pyrrolo-dC. RP-HPLC 
chromatogram (left) and nucleoside ratios (right) 
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3.2.3 Summary  
Synthesis of the tri-partite ICL DNA was complex with the dG-dG coupling step 
being the most difficult followed by the capping residue containing a levulinyl group. 
Although the crosslinked amidite coupling was increased to 50% and levulinyl capping 
problem solved, purification revealed the presence of two major products (top and bottom 
bands). Characterisation was challenging as all ICL DNA containing pyrrolo-dC showed 
similar nucleoside composition.  
Bi-partite ICL DNA was synthesized and purified to relatively high purity with a 
major set-back in yields due to poor 5’-amidite coupling. Composition analysis showed 
the presence of crosslinked amidite and pyrrolo-dC with the expected ratios. 
3.3 Biophysical analysis of DNA duplexes 
3.3.1 Tri-partite DNA 
3.3.1.1 Thermal denaturation studies 
 Thermal denaturation studies were used to observe thermal stability and possible 
changes that that may occur with the incorporation of modified bases. ICL DNA samples 
revealed significant variations of melting temperatures for bottom band ICL DNAs with 




C, while top band ICL DNA displayed relatively 
constant melting temperatures (see Table 5). The bottom band ICL DNA Tm variations 
are surprising. Could the differences be due to the change in position of the pyrrolo-dC? 
However, when looking at simpler ICL DNA from the bi-partite synthesis we do not 
observe such variances. On the other hand the top bands do show high agreement that 
may be more characteristic of the desired ICL DNA. However, without a complementary 
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method of characterization we could not continue to postulate further the reasons for such 
variance. 
ICL DNA code 
Melting temperature, Tm (
o
C) 
Top band Bottom band 
CJW293 61.1 54.2 
CJW294 61.1 62.1 
CJW295 62.0 66.0 
Table 5 Thermal denaturation studies of tri-partite ICL DNA. 
 A special note must be given to the control sequences containing O
6
-methyl-dG in 
contrast to unmodified DNA and sequences containing pyrrolo-dC (see Figure 28). 
Firstly, incorporation of O
6





C, where both unmodified DNA and DNA containing pyrrolo-dC 
have the same Tm. A decrease in stability was expected as the modified base cannot base 
pair as efficiently as its naturally occurring dG. As expected pyrrolo-dC incorporation in 
the opposing strand did not result in a change of thermal stability. However, surprisingly 
when pyrrolo-dC is directly opposed to O
6
-methyl-dG (CJW272/271) we observed an 
increase of 3
o
C in thermal stability. It appears that pyrrolo-dC is able to partially reduce 
the instability caused by the modified dG. This possibly could be due to the extra 
aromatic ring that pyrrolo-dC has and dC does not, which may lead to increased stacking 
interactions, however more analysis is required. 
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Figure 28 Thermal denaturation studies of DNA controls containing O
6
-methyl-dG 
(CJW271), unmodified DNA (CJW269, CJW270) and pyrrolo-dC directly opposed to 
O
6
-methyl-dG (CJW272) or positions  flanking O
6
-methyl-dG (CJW273, CJW274). 
3.3.1.2 Structural analysis 
 Circular dichroism was used to determine DNA structure and to observe any 
changes that may have occurred upon incorporation of modified nucleosides. All controls 
with and without pyrrolo-dC or the O
6
-methyl-dG showed comparable B-form 
conformations. Although the height of the peaks and valleys vary in size (at 250nm and 
280 nm respectively), the shape remains similar and therefore all DNA are considered to 
be B-form (see Figure 29). The differences between the three samples are not 
considerable enough to suggest a major change in conformation, for example: a transition 
from B-form to A-form DNA. Structural analysis confirmed that all ICL DNA (both top 
and bottom bands) retained B-form conformation and that incorporation did not result in 
major structural double helix distortion. Unfortunately CD analysis of the ICL DNAs did 































CJW269/271    54.0°C
CJW272/271    57.0°C
CJW273/271    54.0°C
CJW274/271    54.0°C
CJW270/272    62.1°C
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Figure 29 CD comparison of ICL DNA top and bottom bands with unmodified DNA for 
CJW293. 
3.3.2 Bi-partite DNA 
3.3.2.1 Thermal denaturation studies 





-dG ICL DNA, thermal denaturation studies were conducted. We observed an increase 
in thermal stability with the presence of the crosslink, with an increase of 4-6
o
C relative 
to the corresponding unmodified (not crosslinked) DNA duplex. This increase may be 
due to the covalent linkage that pre-organizes the duplex (see Figure 30). The ICL 
duplexes containing the pyrrolo-dC exhibit Tm values, using the first derivative maxima, 
similar to the ICL duplex (≈ ±1oC) on thermal stability of dsDNA with and without a 
crosslink (not shown). The Tm curves suggest that the ICL duplexes are not denatured 
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Figure 30 Thermal denaturation studies of unmodified DNA, ICL and ICLpyrrolo1. 
3.3.2.2 Structural comparison analysis  
 To confirm that the various duplexes retained B-form conformation and that 
incorporation did not result in major structural double helix distortion, CD was used. The 
control (unmodified) DNA exhibited a large positive signal at 280nm diagnostic of a B-
form duplex. Presence of the ICL and pyrrolo-dC does not appear to have any significant 































Unmodified DNA    45.0°C
ICL                         49.0°C
ICLpyrrolo1            50.0°C
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Figure 31 Far-UV CD signal comparison between unmodified DNA, ICL and 
ICLpyrrolo1. 
3.3.3 Summary  
Characterisation was challenging as all tri-partite ICL DNA containing pyrrolo-
dC showed similar CD data (all B-form). Furthermore, thermal denaturation studies did 
not conclusively reveal which major product contains the desired ICL, with major 
variance in melting temperature for bottom band samples. Therefore, another mode of 
identification of ICL DNA is needed. In addition, a special note was taken for pyrrolo-
dC’s ability to reduce instability caused by O6-methyl-dG when directly opposed by 
showing an increase in thermal stability of 3
o
C. Further optimization of the tri-partite 
synthesis is required and could lead to the development of more complex DNA 
substrates. In addition, all bi-partite ICL oligonucleotides demonstrated favourable and 
increased thermal stability without major disruption of the DNA double helix as 
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3.4 Repair, Binding and fluorescence studies of bi-partite ICL DNA with 
AGTs 
3.4.1 Repair studies 
 Radioactivity repair assays were conducted to observe whether the presence of the 
pyrrolo-dC affected ICL repair. Initial overnight repair studies indicated that Ada-C does 
not repair ICL DNA or form any median products. In addition, there was an unexpected 
issue with the C145S protein variant showing an apparent degradation of the ICL DNA. 
It was hypothesized that the C145S mutant was able to scavenge a divalent cation 
(possibly zinc or magnesium) that increased the protein’s activity. To eliminate this, 
assays were performed with the addition of EDTA. Analysis of the labelled products by 
PAGE revealed that EDTA did in fact remove C145S’s apparent activity without 
significantly affecting wild type AGT’s ability to repair ICL DNA (O6-dG-heptylene-O6-
dG, see Figure 32).  
 
Figure 32 20% polyacrylamide gel of overnight incubation of DNA (D), AGT wild type 
(wt) and C145S (C) in the presence and absence of EDTA.  
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 Time course assays of AGT wild type and variants with the substrates ICL, 
ICLpyrrolo1 and ICLpyrrolo2 were conducted. Percent repaired values were obtained by 
selecting and comparing the regions corresponding to unrepaired ICL DNA, repaired 
products and median products. C145S and R128A clearly were unable to repair any ICL 
DNA (middle and bottom graph of Figure 33, ICL repair data not shown). Also, the 
arginine ―finger‖ (R128A) appears not only to be essential for mono-adduct repair but 
also ICL damage. The apparent 5% repaired ICLpyrrolo1 of the middle graph for C145S 
and R128A is due to slight degradation of the ICL DNA and not due to the protein. As 
for AGT wild type protein, pyrrolo-dC does not appear to have a significant effect on the 
amount of overall repair, as observed error bars tend to overlap around 120 minutes (top 
graph Figure 33).  
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Figure 33 Radioactivity repair assays done in triplicate comparing AGT wild type (6 
mM) with all ICL DNAs (0.13 mM, top graph) and AGT variants repair of ICLpyrrolo1 
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3.4.2 Binding studies  
 All proteins unable to repair ICL DNA were used for binding assays. The binding 
affinity was most important as a determinant factor to choose an AGT variant for 
fluorescent binding studies. Table 6 shows results of binding of C145S, R128A and Ada-
C to unmodified DNA, ICL, ICLpyrrolo1 and ICLpyrrolo2.  As observed in Figure 34 
top, increasing concentration of protein results in increased binding of DNA and 
migration of bands to the upper band position. Constants of dissociation (Kd) were 
calculated using the equations as shown in section 2.25. 
 
Figure 34 An example of binding data of C145S protein of various concentrations with 
0.5 nM of DNA CJW322/323, with the polyacrylamide gel on top and the Hill plot 
analysis of the raw data on bottom. Lanes A-H of the gel contained DNA and designates 
the following: (A) DNA only, (B) 0.36 µM C145S, (C) 0.48 µM C145S, (D) 0.84 µM 
C145S, (E) 0.96 µM C145S, (F) 1.08 µM C145S, (G) 1.20 µM C145S and (H) 1.32 µM 
C145S. 
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C145S showed the strongest binding with Kd values for ICL and non-ICL 
containing DNA within the same order of magnitude. We would have thought that ICL 
DNA would be bound more strongly because, as a repair protein, we would assume AGT 
would preferentially bind damaged DNA to repair it. C145S binds more efficiently than 
R128A (ICL DNA only) and Ada-C. R128A binds very poorly to unmodified DNA but 
not with ICL DNA. Whereas Ada-C binds most inefficiently to both ICL and non-ICL 
DNA, with a slight increase in binding strength for ICL DNA over unmodified DNA. The 
presence of pyrrolo-dC did not result in significant differences in AGT binding.  
Binding data suggests that the R128 residue is not essential for detecting damage 
but is required to associate with unmodified DNA, hinting at the possible mechanism of 
damage detection. Given R128A’s binding preferences it is plausible that damage 
detection is completed by detecting intrahelical and capturing extrahelical modifications 
as Duguid had postulated and not by flipping out each base. However, more mutants such 
as modification of tyrosine 114 are required to provide more information. It must be 
noted that pyrrolo-dC did not significantly affect AGT variants binding. Furthermore, 
when comparing to simpler oligonucleotides it is possible that larger DNA substrates will 
show similar results and smaller dissociation constants, whereas shorter DNA substrates 
will shower a greater variance in Kd values between ICL and non-ICL containing DNA. 
Furthermore, the strongest binding protein C145S showed overall dissociation constants 
(Kd) in the high nM range, where R128A and Ada-C binds at least 10 times less strongly. 
 
 
 70 | P a g e  
 
DNA 
Overall protein dissociation constants Kd (μM) 
C145S R128A Ada-C 
Unmodified DNA 0.578±0.005 ND* 22.72±6.96 
ICL 0.249±0.012 2.924±0.575 10.53±1.25 
ICLpyrrolo1 0.141±0.014 4.442±0.846 4.268±0.883 
ICLpyrrolo2 0.163±0.014 7.322±0.008 7.554±0.010 
Table 6 Apparent binding dissociation constants of AGT C145S, R128A and E. coli 
homolog Ada-C. ND* no definitive Kd value could be determined up to 100μM. 
3.4.3 Fluorescence binding studies 
 Fluorescence binding experiments were conducted using pyrrolo-dC containing 
DNA to attempt to elucidate AGT’s association with ICL DNA. During optimization it 
was determined that dsDNA with and without pyrrolo-dC do not fluoresce, with the 
buffer having no significant fluorescence profile. Upon the addition of protein there is a 
significant increase in fluorescence, where increasing fluorescence can often be observed 
with increasing protein concentration depending on the presence of ICL and the position 
of pyrrolo-dC (Figure 35 bottom shows an example of spectra). In addition, protein 
samples without DNA appear to fluoresce and overshadow pyrrolo-dC fluorescence, 
which was unexpected (Figure 35 top). Therefore, all fluorescence spectra were 
corrected for protein fluorescence by subtracting fluorescence as observed with protein 
and buffer only (Figure 35 top) with each protein sample with DNA. It must be noted, 
however, that increasing protein concentration tended to increase background 
fluorescence, which could most possibly be due to the presence of oxidized DTT, as 
proteins do not tend to fluoresce with excitation at 346nm.  We were able to reduce 
background fluorescence by using a more concentrated protein stock solution, yet for 
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concentration above 9μM another reducing agent, such as TECEP, could be investigated 
as solubility becomes an issue for highly concentrated protein stock solutions.  
 
Figure 35 Fluorescence spectra of buffer with varying concentrations of C145S protein 
(top) and corrected fluorescence spectra of 391 nM ICLpyrrolo1 DNA with varying 
amounts of C145S protein (bottom).  
 72 | P a g e  
 
Fluorescence binding studies were conducted with C145S with ICL and non-ICL 
containing DNA. We observed that pyrrolo-dC exhibited greater fluorescence when 
located at the 5’-end (pyrrolo2 position) rather than a central location (pyrrolo1 position) 
for DNA duplexes lacking and containing the ICL (see Figure 36). Although the 
pyrrolo1 position shows lower overall fluorescence, there is a constant increase as protein 
concentration increases (Figure 35 bottom and 36 top). The difference between ICL and 
non-ICL containing DNA for pyrrolo1 is minimal with both demonstrating similar trends. 
Furthermore, the pyrrolo2 position may show overall greater fluorescence but the least 
difference in fluorescence as protein concentration increases (Figure 36 bottom). In 
addition, unmodified DNA spectra appear to have increased fluorescence as compared to 
ICL containing DNA for pyrrolo2.  
The fluorescence spectra of pyrrolo1 and pyrrolo2 presents an issue as we can no 
longer specify whether the difference in fluorescence between the two positions is due to 
the presence of the crosslink or not. The pyrrolo1 position may fluoresce less due to 
increased stability in the center of a double helix and the presence of the crosslink. While, 
greater fluorescence at the 5’-end suggests that pyrrolo-dC is in a more dynamic 
environment where the double helix can open more readily (being near the end of the 
helix), which is possibly independent of significant changes in AGT concentration. 
Furthermore, the difference observed between ICL and non-ICL DNA for the pyrrolo2 
position (Figure 36 bottom) may be due to the presence of single stranded DNA in the 
control sample (for increased fluorescence) and/or the presence of ICL (for decreased 
fluorescence for ICLpyrrolo2).  
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While we did not observe a maximum fluorescence for the amounts of protein 
used, it is possible that dissociation constants could be determined. However, more work 
has to be done as this was completed once, a maximum fluorescence was not reached and 
a more pure substrate must be used in conjunction with other protein variants to observe 
consistency.  
 Further optimization of the fluorescence assay coupled with the use of a greater 
variety of AGT variants may aid in elucidating AGT association with ICL DNA. 
Specifically C145S binding curves could be used as a standard with which to compare all 
other protein variants. Alternatively, fluorescence binding experiments can be used to 
possibly determine dissociation constants, providing a safer non-radioactive option. 
Unfortunately based on the fluorescence data obtained we cannot definitively determine 
the extent of DNA double helix melting due to AGT bound to ICL damage. 
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Figure 36 Comparison of fluorescence intensities at 455nm as C145S protein 
concentration increases with 391 nM DNA. ICLpyrrolo1 is compared to its pyrrolo-dC 
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3.4.4 Summary 
 Repair assays revealed the apparent activity of C145S, which was removed upon 
the addition of EDTA. Furthermore, the R128A variant proved that the arginine ―finger‖ 
plays an essential role in ICL DNA repair. Binding assays illustrated C145S’s strong 
binding affinity to both unmodified DNA and ICL DNA with R128A and Ada-C binding 
less strongly. In addition, R128A’s very weak binding to unmodified DNA was a surprise 
as it was able to bind ICL DNA suggesting R128A may be required to associate with 
unmodified DNA but that it does not play an essential role in damage detection. 
 Fluorescence studies did not specifically demonstrate the extent to which AGT 
melts the double helix upon binding ICL DNA over non-ICL containing DNA. In 
addition, pyrrolo appears to fluoresce more when positioned near the 5’-end (pyrrolo2) 
than when centrally positioned (pyrrolo1) for both ICL and non-ICL DNA. This results in 
lower overall fluorescence at the pyrrolo1 position. Future work with protein variants 
may reveal important residue for binding and damage detection, using C145S binding 
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Conclusion 
We attempted to understand the influence of AGT binding and effect on the 





-2’-deoxyguanosine (O6-dG-alkylene-O6-dG) ICL in a 5’-GNC-3’ motif  
that mimics the lesion formed by hepsulfam. To better understand the effect of AGT 
binding, we also incorporated pyrrolo-dC at various positions. 
Several AGT variants (AGT wild type, C145S mutant, R128A mutant and Ada-
C) were expressed and prepared to high purity, identified by MS-Q-TOF and 
biophysically characterized, showing that they were stable above 37
o
C and properly 
folded.  
Synthesis of the ICL DNA (tri-partite synthesis) proved difficult with the 
crosslink coupling yield being poor and the residue (Lev-dC) properly capping the 5’-
ends from undesired extension.  Most significantly purification revealed the presence of 
two major products (top and bottom bands). Standard characterization methods proved 
futile in identifying the desired product, as all ICL DNA containing pyrrolo-dC showed 
similar DNA composition, overlapping CD data (all B-form) and thermal denaturation 
studies did not provide any conclusive results. Surprisingly, pyrrolo-dC seemed to reduce 
stability induced by incorporation of O
6
-methyl-dG directly opposed by increasing 
thermal stability by several degrees. 
As we could not identify the desired product of the tri-partite project, we 
prepared ICL DNA (bi-partite synthesis) with a presence of minor impurities, due to poor 
5’-amidite coupling, which could not be removed without significant loss of product. ICL 
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compositional analysis confirmed the identity of the desired products and the presence of 
both crosslink and pyrrolo-dC. ICL incorporation appeared to increase thermal stability 
by 5
o
C while not causing substantial distortion of the double helix. Importantly, the 
fluorophore did not seem to decrease thermal stability, nor cause distortion of the B-form 
DNA and did not significantly affect AGT’s ability to repair and bind ICL DNA. Repair 
assays revealed that the R128A variant was unable to repair ICL DNA and the apparent 
activity of C145S, which was removed in the presence of EDTA. Binding assays 
illustrated C145S’s strong binding affinity with R128A and Ada-C binding less strongly. 
Surprisingly R128A bound very weakly to unmodified DNA while it was able to bind 
ICL DNA suggesting that it may not play an essential role in damage detection. 
Fluorescence studies with C145S were unable to solve the ICL-AGT association 
dilemma, however could possibly be used to provide approximate dissociation constants. 
Fluorescence appeared to be quenched more for centrally located pyrrolo-dC’s as 
compared to those nearer to the 5’-end. The fluorescence data obtained provides a base 
with which to further develop the fluorescence assay to possibly elucidate protein mutant 
binding to various oligonucleotides. 
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Future work 
 Development of new AGT variants, such as mutagenesis of the residue tyrosine 
114, may reveal residues with novel functions and aid in solving the damage detection 
and ICL-AGT association dilemmas. In addition, an in-depth search into the effects of 
zinc and other divalent cation on AGT activity may reveal the specific changes in 
stability and structure as well as explaining what caused C145S’s apparent activity. 
Furthermore, we would like to improve upon the tri-partite synthesis, as it allows for a 
more diverse base sequence in a non-symmetrical fashion. In addition, further refinement 
of the synthesis of the bi-partite synthesis ICL DNA should be completed in order to 
reduce oligonucleotide by-products, and hence identify ICL DNA using Orbitrap MS, 
which can be used to improve repair and binding studies. Most importantly, we would 
like to see further optimization of the fluorescence experiments in tandem with 
development of AGT variants and new more complex DNA substrates. This development 
could help to understand the quenching effect due to pyrrolo’s position, and more 
significantly, elucidate AGT’s method of damage detection and ICL repair. Furthermore, 
identification of possible binding partners to AGT and the function of the N-terminal 
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